Ostryy Limfoblastnyy Leykoz U Detey
AUTHOR | Manchuk Valeriy; Kadricheva Tat'yana |
PUBLISHER | LAP Lambert Academic Publishing (12/20/2013) |
PRODUCT TYPE | Paperback (Paperback) |
Description
Ostryy limfoblastnyy leykoz yavlyaetsya naibolee chastoy formoy sredi zlokachestvennykh zabolevaniy krovi v detskom vozraste. Sozdanie i vnedrenie v praktiku sovremennykh programm khimioterapii privelo k znachitel'nomu uluchsheniyu rezul'tatov lecheniya OLL, v remissiyu vykhodit 95-98% bol'nykh. Odnako, nesmotrya na dostignutye uspekhi, ostaetsya nemalo problem, ukhudshayushchikh rezul'taty lecheniya OLL. Odnoy iz nikh yavlyaetsya vysokaya infektsionnaya zabolevaemost' i smertnost' ot infektsionnykh oslozhneniy. Khimioterapiya i glyukokortikosteroidy - obyazatel'nye komponenty lecheniya OLL, privodyat k razvitiyu oslozhneniy i yavlyayutsya faktorom, predraspolagayushchim k razvitiyu defektov vsekh zven'ev immuniteta, v tom chisle kolichestvennykh i kachestvennykh kharakteristik neytrofil'nykh granulotsitov. V nastoyashchey rabote pokazano, chto normal'noe soderzhanie neytrofilov na fone terapii ostrogo limfoblastnogo leykoza ne soprovozhdaetsya vosstanovleniem ikh funktsional'noy aktivnosti, v chastnosti, sposobnosti k generatsii aktivnykh form kisloroda. Tselevaya auditoriya - vrachi gematologi, onkologi, spetsialisty v oblasti patologicheskoy fiziologii, immunologii, studenty meditsinskikh vuzov.
Show More
Product Format
Product Details
ISBN-13:
9783659495878
ISBN-10:
3659495875
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
Russian
More Product Details
Page Count:
84
Carton Quantity:
84
Product Dimensions:
6.00 x 0.20 x 9.00 inches
Weight:
0.30 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | General
Descriptions, Reviews, Etc.
publisher marketing
Ostryy limfoblastnyy leykoz yavlyaetsya naibolee chastoy formoy sredi zlokachestvennykh zabolevaniy krovi v detskom vozraste. Sozdanie i vnedrenie v praktiku sovremennykh programm khimioterapii privelo k znachitel'nomu uluchsheniyu rezul'tatov lecheniya OLL, v remissiyu vykhodit 95-98% bol'nykh. Odnako, nesmotrya na dostignutye uspekhi, ostaetsya nemalo problem, ukhudshayushchikh rezul'taty lecheniya OLL. Odnoy iz nikh yavlyaetsya vysokaya infektsionnaya zabolevaemost' i smertnost' ot infektsionnykh oslozhneniy. Khimioterapiya i glyukokortikosteroidy - obyazatel'nye komponenty lecheniya OLL, privodyat k razvitiyu oslozhneniy i yavlyayutsya faktorom, predraspolagayushchim k razvitiyu defektov vsekh zven'ev immuniteta, v tom chisle kolichestvennykh i kachestvennykh kharakteristik neytrofil'nykh granulotsitov. V nastoyashchey rabote pokazano, chto normal'noe soderzhanie neytrofilov na fone terapii ostrogo limfoblastnogo leykoza ne soprovozhdaetsya vosstanovleniem ikh funktsional'noy aktivnosti, v chastnosti, sposobnosti k generatsii aktivnykh form kisloroda. Tselevaya auditoriya - vrachi gematologi, onkologi, spetsialisty v oblasti patologicheskoy fiziologii, immunologii, studenty meditsinskikh vuzov.
Show More
Your Price
$51.17